B21-High Throughput SAXS
I03-Macromolecular Crystallography
VMXi-Versatile Macromolecular Crystallography in situ
|
Maya
Noureddine
,
Halina
Mikolajek
,
Nathan
Cowieson
,
Nikos
Pinotsis
,
Paul
Robinson
,
Alexandre
Slater
,
Charles
Redwood
,
Siobhan
Loughna
,
Chris
Denning
,
Fiyaz
Mohammed
,
Katja
Gehmlich
Diamond Proposal Number(s):
[34438]
Open Access
Abstract: Hypertrophic cardiomyopathy (HCM) is a genetic disease associated with sudden cardiac death. Variants in alpha-actinin-2 (ACTN2), a Z-disc protein that anchors actin thin filaments have been implicated in HCM, yet their structural consequences remain poorly defined. Here, we characterise seventeen HCM-associated ACTN2 variants spanning multiple domains using an integrated and tiered workflow combining high-throughput assays, structural modelling and biophysical approaches. All variants display reduced solubility, with actin-binding domain (ABD) substitutions showing pronounced thermal instability by differential scanning fluorimetry. Modelling of nine variants predicts diverse pathogenic mechanisms including compromised actin-binding, impaired ABD regulatory conformations, disrupted dimerisation interfaces, and perturbed domain architecture. Crystal structures of two rod-domain variants reveal intact dimerisation despite modelling predictions. Actin-binding assays for ABD variants confirm altered actin engagement suggesting that binding dynamics may drive pathogenicity. Limited proteolysis indicates reduced structural stability across variants, while size-exclusion chromatography coupled with multi-angle light scattering or small-angle X-ray scattering (SEC-MALS/SAXS) shows a strong propensity for aggregation. Batch-mode SAXS further demonstrates early aggregation onset in selected ABD variants at elevated temperatures. Collectively, these findings establish that HCM-linked ACTN2 variants compromise protein integrity through multiple mechanisms, highlight the ABD as a hotspot of vulnerability and provide a potential framework for interpreting cardiomyopathy-associated variants.
|
Jul 2026
|
|
|
|
Maya
Noureddine
,
Fiyaz
Mohammed
,
Halina
Mikolajek
,
Nathan
Cowieson
,
Paul
Robinson
,
Chris
Denning
,
Siobhan
Loughna
,
Nikos
Pinotsis
,
Bethany
Jones
,
Alexandre
Slater
,
Rachel
Myles
,
Caroline
Coats
,
Sophie
Broadway-Stringer
,
Katja
Gehmlich
Open Access
Abstract: Introduction:
Z-disk proteins play an essential role in stabilizing the contractile muscle apparatus. Genetic variants in these proteins are associated with cardiomyopathies, a group of genetic cardiac diseases linked to sudden cardiac death. Several studies have identified pathogenic variants in two prominent Z-disk proteins, alpha-actinin (ACTN2) and filamin C (FLNC). Notably, a 2014 study identified the ACTN2 variant M228T in a family of 11 patients with cardiomyopathy. Similarly, a recent investigation uncovered the FLNC variant M82K in two cardiomyopathy families. Both variants reside within the actin-binding domain of their respective Z-disk proteins, which is crucial for organizing and binding actin-thin filaments. However, the mechanisms by which these variants alter protein structure and function remain undefined.
This study investigated the structural alterations and functional consequences associated with the ACTN2-M228T and FLNC-M82K variants.
Methods:
To explore the structural modifications in the ACTN2-M228T and FLNC-M82K mutant proteins, structural modelling approaches were employed. Additionally, recombinant proteins were expressed in a bacterial system and subsequently purified. A comprehensive array of biophysical techniques was utilized to detect alterations in protein structure. Functional assessments were performed using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) that incorporated the ACTN2-M228T variant.
Results:
Structural modeling predictions revealed that both ACTN2-M228T and FLNC-M82K variants share a common mechanism that adversely impact the regulatory function of the actin-binding domain. This hypothesis was further evaluated using actin-binding assays. The mutant proteins exhibited increased aggregation identified through mass photometry and size exclusion chromatography coupled with either multi-angle light scattering or small-angle X-ray scattering (SAXS). Moreover, both variants demonstrated reduced solubility and structural stability based on solubility and enzymatic digestion assays. The thermal stability of mutant proteins was also compromised, as assessed through SAXS and differential scanning fluorimetry.
To correlate the identified structural alterations with disease mechanisms, the functional implications of ACTN2-M228T variant were assessed using an iPSC-CM model. Mutant cardiomyocytes showed increased ACTN2 aggregate formation and upregulation of hypertrophy, fibrosis, and autophagy markers. Furthermore, significant degradation of ACTN2 was observed through biochemical fractionation assays. ACTN2 destabilization was further evaluated using proteasome and protease inhibitors targeting the ubiquitin-proteosome system and the autophagy-lysosomal pathway, to elucidate their potential roles in the protein degradation process.
Conclusion:
Collectively, this study provides valuable insights into the effects of Z-disk variants on protein structure and function. The integration of structural and functional approaches represents a crucial step towards understanding disease pathways for cardiomyopathy-linked Z-disk variants.
|
Mar 2026
|
|
I04-Macromolecular Crystallography
|
Tom D.
Bunney
,
Hunter G.
Nyvall
,
Calum
Macrae
,
Damjan
Lalović
,
Ashley
Gregory
,
Kyle I. P.
Le Huray
,
Nikita
Harvey
,
Nikos
Pinotsis
,
Antreas C.
Kalli
,
Christopher A.
Waudby
,
John E.
Burke
,
Matilda
Katan
Diamond Proposal Number(s):
[30393]
Open Access
Abstract: Phospholipase C gamma (PLCγ) enzymes are key components of intracellular signal transduction processes and are involved in disease development, including immune dysregulation, specific cancer types and neurodegeneration. Although recognised as important targets for intervention, validated pharmacological tools are lacking. Here, we demonstrate that inhibitory nucleotides bind directly to an allosteric site at the interface between the PLC-core and regulatory-array unique for PLCγ, underlying their specificity for the PLCγ family. This binding site overlaps with the PLCγ autoinhibitory interface, suggesting that the inhibitory impact of nucleotides involves stabilisation of autoinhibition. We have also analysed disease-linked variants of PLCγ1 and PLCγ2 to show that multiple mechanisms could underpin their gain-of-function phenotype. While the sensitivity of these variants to physiological nucleotide inhibition is reduced, we identified artificial nucleotide compounds that can inhibit such variants not only in vitro but also in cell-based assays. Therefore, our findings suggest a route for development of isozyme specific PLCγ inhibitors allowing further studies of their roles in health and disease.
|
Oct 2025
|
|
I03-Macromolecular Crystallography
|
Diamond Proposal Number(s):
[17201]
Open Access
Abstract: N-utilization substance A (NusA) is a regulatory factor with pleiotropic functions in gene expression in bacteria. Archaea encode two conserved small proteins, NusA1 and NusA2, with domains orthologous to the two RNA binding K Homology (KH) domains of NusA. Here, we report the crystal structures of NusA2 from Sulfolobus acidocaldarius and Saccharolobus solfataricus obtained at 3.1 Å and 1.68 Å, respectively. NusA2 comprises an N-terminal zinc finger followed by two KH-like domains lacking the GXXG signature. Despite the loss of the GXXG motif, NusA2 binds single-stranded RNA. Mutations in the zinc finger domain compromise the structural integrity of NusA2 at high temperatures and molecular dynamics simulations indicate that zinc binding provides an energy barrier preventing the domain from reaching unfolded states. A structure-guided phylogenetic analysis of the KH-like domains supports the notion that the NusA2 clade is ancestral to the ribosomal protein eS7 in eukaryotes, implying a potential role of NusA2 in translation.
|
Nov 2024
|
|
B21-High Throughput SAXS
|
Diamond Proposal Number(s):
[30393]
Open Access
Abstract: The β-coronavirus family, encompassing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Severe Acute Respiratory Syndrome Coronavirus (SARS), and Middle East Respiratory Syndrome Coronavirus (MERS), has triggered pandemics within the last two decades. With the possibility of future pandemics, studying the coronavirus family members is necessary to improve knowledge and treatment. These viruses possess 16 non-structural proteins, many of which play crucial roles in viral replication and in other vital functions. One such vital protein is non-structural protein 10 (nsp10), acting as a pivotal stimulator of nsp14 and nsp16, thereby influencing RNA proofreading and viral RNA cap formation. Studying nsp10 of pathogenic coronaviruses is central to unraveling its multifunctional roles. Our study involves the biochemical and biophysical characterisation of full-length nsp10 from MERS, SARS and SARS-CoV-2. To elucidate their oligomeric state, we employed a combination of Multi-detection Size exclusion chromatography (Multi-detection SEC) with multi-angle static light scattering (MALS) and small angle X-ray scattering (SAXS) techniques. Our findings reveal that full-length nsp10s primarily exist as monomers in solution, while truncated versions tend to oligomerise. SAXS experiments reveal a globular shape for nsp10, a trait conserved in all three coronaviruses, although MERS nsp10, diverges most from SARS and SARS-CoV-2 nsp10s. In summary, unbound nsp10 proteins from SARS, MERS, and SARS-CoV-2 exhibit a globular and predominantly monomeric state in solution.
|
Sep 2023
|
|
I23-Long wavelength MX
|
Diamond Proposal Number(s):
[30393, 2322]
Open Access
Abstract: The identification of multiple simultaneous orientations of small molecule inhibitors binding to a protein target is a common challenge. It has recently been reported that the conformational heterogeneity of ligands is widely underreported in the Protein Data Bank, which is likely to impede optimal exploitation to improve affinity of these ligands. Significantly less is even known about multiple binding orientations for fragments (<300 Da), although this information would be essential for subsequent fragment optimisation using growing, linking or merging and rational structure-based design. Here, we use recently reported fragment hits for the SARS-CoV-2 non-structural protein 1 (nsp1) N-terminal domain to propose a general procedure for unambiguously identifying binding orientations of 2-dimensional fragments containing either sulphur or chloro substituents within the wavelength range of most tunable beamlines. By measuring datasets at two energies, using a tunable beamline operating in vacuum and optimised for data collection at very low X-ray energies, we show that the anomalous signal can be used to identify multiple orientations in small fragments containing sulphur and/or chloro substituents or to verify recently reported conformations. Although in this specific case we identified the positions of sulphur and chlorine in fragments bound to their protein target, we are confident that this work can be further expanded to additional atoms or ions which often occur in fragments. Finally, our improvements in the understanding of binding orientations will also serve to improve the rational optimisation of SARS-CoV-2 nsp1 fragment hits.
|
Jul 2023
|
|
I03-Macromolecular Crystallography
I04-Macromolecular Crystallography
I24-Microfocus Macromolecular Crystallography
|
Grace Q.
Gong
,
Benoit
Bilanges
,
Ben
Allsop
,
Glenn
Masson
,
Victoria
Roberton
,
Trevor
Askwith
,
Sally
Oxenford
,
Ralitsa R.
Madsen
,
Sarah E.
Conduit
,
Dom
Bellini
,
Martina
Fitzek
,
Matt
Collier
,
Osman
Najam
,
Zhenhe
He
,
Ben
Wahab
,
Stephen H.
Mclaughlin
,
A. W. Edith
Chan
,
Isabella
Feierberg
,
Andrew
Madin
,
Daniele
Morelli
,
Amandeep
Bhamra
,
Vanesa
Vinciauskaite
,
Karen E.
Anderson
,
Silvia
Surinova
,
Nikos
Pinotsis
,
Elena
Lopez-Guadamillas
,
Matthew
Wilcox
,
Alice
Hooper
,
Chandni
Patel
,
Maria A.
Whitehead
,
Tom D.
Bunney
,
Len R.
Stephens
,
Phillip T.
Hawkins
,
Matilda
Katan
,
Derek M.
Yellon
,
Sean M.
Davidson
,
David M.
Smith
,
James B.
Phillips
,
Richard
Angell
,
Roger L.
Williams
,
Bart
Vanhaesebroeck
Diamond Proposal Number(s):
[28677]
Abstract: Harnessing the potential beneficial effects of kinase signalling through the generation of direct kinase activators remains an underexplored area of drug development. This also applies to the PI3K signalling pathway, which has been extensively targeted by inhibitors for conditions with PI3K overactivation, such as cancer and immune dysregulation. Here we report the discovery of UCL-TRO-1938 (referred to as 1938 hereon), a small-molecule activator of the PI3Kα isoform, a crucial effector of growth factor signalling. 1938 allosterically activates PI3Kα through a distinct mechanism by enhancing multiple steps of the PI3Kα catalytic cycle and causes both local and global conformational changes in the PI3Kα structure. This compound is selective for PI3Kα over other PI3K isoforms and multiple protein and lipid kinases. It transiently activates PI3K signalling in all rodent and human cells tested, resulting in cellular responses such as proliferation and neurite outgrowth. In rodent models, acute treatment with 1938 provides cardioprotection from ischaemia–reperfusion injury and, after local administration, enhances nerve regeneration following nerve crush. This study identifies a chemical tool to directly probe the PI3Kα signalling pathway and a new approach to modulate PI3K activity, widening the therapeutic potential of targeting these enzymes through short-term activation for tissue protection and regeneration. Our findings illustrate the potential of activating kinases for therapeutic benefit, a currently largely untapped area of drug development.
|
May 2023
|
|
I02-Macromolecular Crystallography
I04-1-Macromolecular Crystallography (fixed wavelength)
|
Lorena
Zuliani-Alvarez
,
Morten L.
Govasli
,
Jane
Rasaiyaah
,
Chris
Monit
,
Stephen O.
Perry
,
Rebecca P.
Sumner
,
Simon
Mcalpine-Scott
,
Claire
Dickson
,
K. M.
Rifat Faysal
,
Laura
Hilditch
,
Richard J.
Miles
,
Frederic
Bibollet-Ruche
,
Beatrice H.
Hahn
,
Till
Boecking
,
Nikos
Pinotsis
,
Leo C.
James
,
David A.
Jacques
,
Greg J.
Towers
Diamond Proposal Number(s):
[8547, 11235]
Open Access
Abstract: Of the 13 known independent zoonoses of simian immunodeficiency viruses to humans, only one, leading to human immunodeficiency virus (HIV) type 1(M) has become pandemic, causing over 80 million human infections. To understand the specific features associated with pandemic human-to-human HIV spread, we compared replication of HIV-1(M) with non-pandemic HIV-(O) and HIV-2 strains in myeloid cell models. We found that non-pandemic HIV lineages replicate less well than HIV-1(M) owing to activation of cGAS and TRIM5-mediated antiviral responses. We applied phylogenetic and X-ray crystallography structural analyses to identify differences between pandemic and non-pandemic HIV capsids. We found that genetic reversal of two specific amino acid adaptations in HIV-1(M) enables activation of TRIM5, cGAS and innate immune responses. We propose a model in which the parental lineage of pandemic HIV-1(M) evolved a capsid that prevents cGAS and TRIM5 triggering, thereby allowing silent replication in myeloid cells. We hypothesize that this capsid adaptation promotes human-to-human spread through avoidance of innate immune response activation.
|
Nov 2022
|
|
I04-Macromolecular Crystallography
|
Diamond Proposal Number(s):
[23853, 30393]
Open Access
Abstract: The regular reappearance of coronavirus (CoV) outbreaks over the past 20 years has caused significant health consequences and financial burdens worldwide. The most recent and still ongoing novel CoV pandemic, caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has brought a range of devastating consequences. Due to the exceptionally fast development of vaccines, the mortality rate of the virus has been curbed to a significant extent. However, the limitations of vaccination efficiency and applicability, coupled with the still high infection rate, emphasise the urgent need for discovering safe and effective antivirals against SARS-CoV-2 by suppressing its replication or attenuating its virulence. Non-structural protein 1 (nsp1), a unique viral and conserved leader protein, is a crucial virulence factor for causing host mRNA degradation, suppressing interferon (IFN) expression and host antiviral signalling pathways. In view of the essential role of nsp1 in the CoV life cycle, it is regarded as an exploitable target for antiviral drug discovery. Here, we report a variety of fragment hits against the N-terminal domain of SARS-CoV-2 nsp1 identified by fragment-based screening via X-ray crystallography. We also determined the structure of nsp1 at atomic resolution (0.99 Å). Binding affinities of hits against nsp1 and potential stabilisation were determined by orthogonal biophysical assays such as microscale thermophoresis and thermal shift assays. We identified two ligand-binding sites on nsp1, one deep and one shallow pocket, which are not conserved between the three medically relevant SARS, SARS-CoV-2 and MERS coronaviruses. Our study provides an excellent starting point for the development of more potent nsp1-targeting inhibitors and functional studies on SARS-CoV-2 nsp1.
|
Oct 2022
|
|
I03-Macromolecular Crystallography
|
Nikos
Pinotsis
,
Karolina
Zielinska
,
Mrigya
Babuta
,
Joan L.
Arolas
,
Julius
Kostan
,
Muhammad Bashir
Khan
,
Claudia
Schreiner
,
Anita
Salmazo
,
Luciano
Ciccarelli
,
Martin
Puchinger
,
Eirini A.
Gkougkoulia
,
Euripedes De Almeida
Ribeiro
,
Thomas C.
Marlovits
,
Alok
Bhattacharya
,
Kristina
Djinovic-Carugo
Abstract: The actin cytoskeleton, a dynamic network of actin filaments and associated F-actin–binding proteins, is fundamentally important in eukaryotes. α-Actinins are major F-actin bundlers that are inhibited by Ca2+ in nonmuscle cells. Here we report the mechanism of Ca2+-mediated regulation of Entamoeba histolytica α-actinin-2 (EhActn2) with features expected for the common ancestor of Entamoeba and higher eukaryotic α-actinins. Crystal structures of Ca2+-free and Ca2+-bound EhActn2 reveal a calmodulin-like domain (CaMD) uniquely inserted within the rod domain. Integrative studies reveal an exceptionally high affinity of the EhActn2 CaMD for Ca2+, binding of which can only be regulated in the presence of physiological concentrations of Mg2+. Ca2+ binding triggers an increase in protein multidomain rigidity, reducing conformational flexibility of F-actin–binding domains via interdomain cross-talk and consequently inhibiting F-actin bundling. In vivo studies uncover that EhActn2 plays an important role in phagocytic cup formation and might constitute a new drug target for amoebic dysentery.
|
Sep 2020
|
|